Simple benchmark for complex dose finding studies (Q5170208): Difference between revisions

@@ Property / DOI @@
-.1111/biom.12158
@@ Property / DOI: 10.1111/biom.12158 / rank @@
-Normal rank
@@ Property / cites work @@
+Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial
+Normal rank
@@ Property / cites work @@
+Coherence principles in dose-finding studies
@@ Property / cites work: Coherence principles in dose-finding studies / rank @@
+Normal rank
@@ Property / cites work @@
+Sequential Implementation of Stepwise Procedures for Identifying the Maximum Tolerated Dose
+Normal rank
@@ Property / cites work @@
+Stochastic approximation and modern model-based designs for dose-finding clinical trials
+Normal rank
@@ Property / cites work @@
+Adaptive designs for dose-finding based on efficacy-toxicity response
+Normal rank
@@ Property / cites work @@
+A Random Walk Rule for Phase I Clinical Trials
@@ Property / cites work: A Random Walk Rule for Phase I Clinical Trials / rank @@
+Normal rank
@@ Property / cites work @@
+Statistical Methods for Rates and Proportions
@@ Property / cites work: Statistical Methods for Rates and Proportions / rank @@
+Normal rank
@@ Property / cites work @@
+Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials
+Normal rank
@@ Property / cites work @@
+Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials
+Normal rank
@@ Property / cites work @@
+Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
+Normal rank
@@ Property / cites work @@
+Dose-Finding Designs for HIV Studies
@@ Property / cites work: Dose-Finding Designs for HIV Studies / rank @@
+Normal rank
@@ Property / cites work @@
+Non-parametric optimal design in dose finding studies
+Normal rank
@@ Property / cites work @@
+Dose-Finding Based on Efficacy-Toxicity Trade-Offs
+Normal rank
@@ Property / cites work @@
+A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials
+Normal rank
@@ Property / cites work @@
+Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios
+Normal rank
@@ Property / cites work @@
+The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Quasi‐Likelihood Approach
+Normal rank
@@ Property / DOI @@
+.1111/BIOM.12158
@@ Property / DOI: 10.1111/BIOM.12158 / rank @@
+Normal rank